Evogene Ltd.
Business
Evogene Ltd. is a computational biology company that applies advanced AI and big-data analytics to accelerate discovery and development of life-science products. It offers computational platforms and tech-engines (MicroBoost AI, ChemPass AI, GeneRator AI) plus experimental validation and screening capabilities to identify and optimize microbial, small-molecule and genetic candidates. Operations are organized through business segments and subsidiaries including Biomica (human health), Lavie Bio and AgPlenus (agriculture), and Casterra and Finally (industrial and food applications). Evogene deploys its technologies via licensing, collaborations and subsidiary-led development across global agricultural, pharmaceutical and industrial channels.
Summary from filing dated 2025-03-27
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-7.83M |
| Total assets | $20.05M |
| Total liabilities | $8.07M |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Evogene Ltd.'s CIK number?
Evogene Ltd.'s SEC CIK number is 0001574565 (1574565). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Evogene Ltd.'s SEC filings?
All of Evogene Ltd.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.